Vanberra Signal

OncoScore

Curated by Signal

Algorithms and image-based biomarkers for cancer detection

Overview

Algorithms and image-based biomarkers for cancer detection. The company has developed image analysis solutions for non-invasive cancer detection and staging using multi-parametric MRI. While the technology is agnostic to cancer type, the company is currently focusing on developing image-based biomarkers for detection and staging of prostate cancer as a means to enhance quality of patient care and improve outcomes.

Key facts

Founded
2016

Business model

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Provides mass spectrometry-based system to genomic and clinical testing laboratories

    Life Sciences TechnologySan Diego, United States
  • Developer of women and baby care devices

    Life Sciences TechnologyMiami, United States
  • POC device for diagnosis of high-risk pregnancy

    Life Sciences TechnologyBoston, United States

About OncoScore

What does OncoScore do?

Algorithms and image-based biomarkers for cancer detection.

Where is OncoScore headquartered?

OncoScore is headquartered in Rockville, United States.

When was OncoScore founded?

OncoScore was founded in 2016.

Which sector is OncoScore in?

OncoScore operates in Life Sciences Technology.

Who are OncoScore's competitors?

Companies similar to OncoScore include Agena Bioscience, Fridababy, and Parsagen Diagnostics.